Contents
- 1 What are paid clinical trials for smokers?
- 2 What are the advantages of participating in paid clinical trials for smokers?
- 3 What are the disadvantages of participating in paid clinical trials for smokers?
- 4 How do highly paid clinical trials for smokers work?
- 5 What do researchers learn from conducting paid clinical trials for smokers?
- 6 Commonly Asked Questions (FAQs)
- 6.1 How much are participants compensated in paid clinical trials for smokers?
- 6.2 How do I find out if I am eligible to participate in a paid clinical trial for smokers?
- 6.3 Will participation in a paid clinical trial for smokers prevent me from leaving prior to completion?
- 6.4 What type of information is normally collected in paid clinical trials for smokers?
- 6.5 How long do paid clinical trials for smokers usually last?
- 6.6 If I am interested in participating in a paid clinical trial for smokers, what questions should I ask?
- 6.7 What to ask:
What are paid clinical trials for smokers?
Paid clinical trials for smokers are designed to explore treatments that aid in quitting or smoking cessation. Major research centers such as the Mayo Clinic’s Nicotine Dependence Center routinely recruit active smokers for nicotine-specific paid clinical trials to better understand how nicotine affects the body. Furthermore, the trials are aimed at finding better avenues to help smokers who wish to quit and lessen their cravings for nicotine substitutes.
Quick Facts: Paid Clinical Trials for Smokers
- Actively recruiting US smoking cessation studies (July 2026): 111 (ClinicalTrials.gov)
- Typical compensation: $25–$100 per completed visit, often with completion or verified-abstinence bonuses
- Cost to participate: $0 — study treatment and visits are covered by the sponsor
- Growing area: vaping and e-cigarette cessation studies are also recruiting
- Find one near you: Browse paid clinical trials by state or see drug addiction clinical trials
2026 Smoking Cessation Research Updates
- First new quit-smoking drug in 20 years is close: Cytisinicline, tested in the ORCA-2 and ORCA-3 trials with more than 2,000 participants, received an FDA Complete Response Letter in June 2026 over third-party manufacturing issues — the agency cited no concerns with its effectiveness or safety. The maker plans to resubmit in late 2026.
- Vaping cessation is the next frontier: the FDA granted cytisinicline a national priority review voucher for e-cigarette cessation, and vaping cessation trials are actively enrolling.
- 111 smoking cessation studies are recruiting across the US as of July 2026, per ClinicalTrials.gov.
How do I find paid clinical trials for smokers near me?
Based upon your personal risk factors, your physician may suggest a paid clinical trial for smokers available your local area. Local hospitals and clinics may also host a presentation by a clinical trial sponsor in your area about paid clinical trials regarding any local opportunities in addition to posting opportunities on most popular social media platforms. We also recommend routinely checking in with state and local government sponsored websites, research hospitals, and educational institutions as they typically have a plethora of current resources for paid clinical trials for smokers.
Who conducts paid clinical trials for smokers?
The clinical sponsors that host paid clinical trials for smokers and nicotine addiction are industry wide. Many clinical sponsors represent partnerships with pharmaceutical giants, research firms, scientific endeavors, and educational partnerships for finding a way to curb nicotine addiction in adults and youth.
Cigarette smoking is responsible for more than 480,000 deaths per year in the United States, including more than 41,000 deaths resulting from secondhand smoke exposure. (Source: CDC)
Paid clinical trial teams consist of a principal investigator, coordinators, and associates that organize, plan, and oversee the clinical study. The study team aims to execute a safe clinical trial while maintaining strict compliance with ethical and regulatory standards.
What are the advantages of participating in paid clinical trials for smokers?
Smoking and secondhand smoke cause long-term adverse health effects and are a precursor to various cancers. Participating in a paid clinical trial for smokers may provide the intervention needed to kick the habit permanently. In addition, the health benefits associated with the studied treatment modality can also provide motivation toward healthy lifestyle changes. The best advantage is that you receive payment for participating and experience rare access to state-of-the-art nicotine treatments and help.
What are the disadvantages of participating in paid clinical trials for smokers?
Unfortunately, conquering a behavioral challenge may be exceedingly difficult – even with help from your paid clinical trial sponsors. Learning new coping strategies paired with drug interventions can sometimes bring up uncomfortable emotions while the body and mind adjust. There may also be a range of discomfort and unwanted side effects from any medications administered to aid smoking cessation. While there is not a one size fits all treatment modality, your personal physician can assist in helping you decide if a paid clinical trial for smokers is a right choice for you.
How do highly paid clinical trials for smokers work?
Most highly paid clinical trials require participants to have exhausted previous methods of treatment to alleviate chronic smoking or extend some degree.
As a participant, you may be asked to use certain medications to help you abstain from tobacco products. Some high-paid clinical trials for smokers may also include behavioral modification counseling and other stringent requirements to receive full payment.
Four phases of clinical trials are needed to receive FDA approval. The classifications target different objectives related to optimizing patient safety.
Smoking cessation trials move through the same four FDA-regulated phases as any other study: Phase I establishes safety and dosing (usually with healthy volunteers, and typically the highest paying), Phases II and III test how well the treatment works in progressively larger groups, and Phase IV monitors long-term safety after approval. Our guide to the types of paid clinical trials explains each phase and what to expect as a participant.
What do researchers learn from conducting paid clinical trials for smokers?
Researchers seek to learn as much as they can about how nicotine affects the brain both temporarily and permanently. They also aim to find treatment avenues that address both the behavioral aspects of nicotine addiction as well as the physiological. By conducting paid clinical trials for smokers, they can better comprehend how certain areas of the brain respond to different drug interventions when combined with adjunctive treatment options such as medication and behavioral health interventions. Participating patients also help researchers identify which drug therapies can effectively lessen nicotine cravings with the least amount of unwanted side effects.
Commonly Asked Questions (FAQs)
-
How much are participants compensated in paid clinical trials for smokers?
Paid clinical trial participants are compensated for any related care and treatments necessary for the duration of the clinical trial phase. Most smoking cessation studies pay $25–$100 per completed visit, often with bonus payments for completing the full study or for lab-verified abstinence. Residential nicotine research stays can pay considerably more.
As a clinical trial participant, you will be expected to engage in routine check-ins, testing, evaluations, and may be asked in return to perform various health-related tasks. It is common when participating in a paid clinical trial for smokers for patients to be required to:
• To maintain a health diary
• Take certain medications
• Allow for routine lab tests
• Allow for neurological testing
• Engage in behavioral therapy -
How do I find out if I am eligible to participate in a paid clinical trial for smokers?
The eligibility criteria for paid clinical trials varies greatly. However, since the aim is directed at smokers and nicotine addiction, it would make sense that they seek long-term smokers with a desire to quit. They also may seek candidates who have tried multiple avenues towards quitting unsuccessfully.
Eligibility for paid clinical trials may also specify other criteria related to:
• Age preferences
• Gender
• Occupation
• Lifestyle
• Preexisting health challenges
• Long-term goals
• Health history -
Will participation in a paid clinical trial for smokers prevent me from leaving prior to completion?
Participation in any clinical trial is strictly voluntary. You can leave at any time for any reason, however, leaving early could affect compensation. Often, paid clinical participants choose to leave because of family obligations, or unforeseen circumstances of some kind. The hope is however, that you will continue and complete the study successfully.
-
What type of information is normally collected in paid clinical trials for smokers?
For those interested in participating in paid clinical trials for smokers, you should expect information requests as it pertains to lifestyle, family history, etc. Researchers will use this information to determine if you are a good fit for the study.
Once determined eligible and you move forward in the trial process, patients typically mustsubmit to routine laboratory testing alongside other necessary treatment modalities. Testing and any information learned along the way, helps to keep you safe and measure the effectiveness of the drug interventions being studied.
-
How long do paid clinical trials for smokers usually last?
There is not a set time for how long paid clinical trials for smokers can last. When you go to find out more information about the study of interest, they may have an idea of what to expect in terms of anticipated time needed for the study. Clinical trial lengths are dependent upon a series of ongoing factors such as:
• Patient recruitment and retention
• Patient health
• The type of paid clinical trial I.e., randomized, double-blind
• Adverse health reactions or results
• Post-clinical trial care and follow-ups -
If I am interested in participating in a paid clinical trial for smokers, what questions should I ask?
Clinical trial investigators must disclose information about the trial and any inherent risk factors. This disclosure process is called informed consent. The NIH maintains clear guidance for the structure and safety of clinical trial execution. There is a strict emphasis on patient safety, and as such, an informed consent disclosure must include the following information:
1. The comprehensive nature of the treatment, procedure, or drug.
2. Any inherent risks associated with the intended treatment methods.
3. Reasonable alternatives to the procedure or treatment intervention.
4. Assessment and acknowledgment that you understand items 1-3.Informed consent is required and articulates the agreement between you, your healthcare physician, and clinical trial sponsors. The purpose of informed consent is to provide the patient with the details of every facet of the intended clinical trial study plan. This goal of informed consent is to establish trust and confidence between the eligible participant and the clinical trial sponsor team leads.
-
What to ask:
– Inquire as to the goals or aim of the highly paid clinical trial.
– Ask what benefits you are entitled to such as post trial care services.
– Clarify the type and means for any out-of-pocket expenses.
– Clarify the exact method of compensation and timeline for payments.
– Clarify any travel and accommodations that may be necessary and their corresponding expenses.
– You may ask if family members may accompany you during hospital stays or doctor visits.
– It would be appropriate to ask questions related to likelihood of discomfort, pain, or side effects that may be experienced.
– Inquire about the number of clinical visits may be expected.
– Ask what home-care services and strategies are available during the paid clinical trial.
– Make sure you are clear on any procedures, drug interactions, and long-term consequences associated with the trial intervention.
– Inquire about the length of speculation of hospital stays along with any associated costs.
– Some clinical studies are randomized trial designs where they include the use of a placebo. Therefore, asking what type of trial design and what is involved with the paid clinical study you are interested in.
– Inquire about the endpoint findings and any access to results.
– Inquire as to the number of patients will be recruited.